QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021

Go back to QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021

Qiagen NV (QGEN) PT Raised to $58 at Cowen

November 4, 2021 5:42 PM EDT

Cowen analyst Dan Brennan raised the price target on Qiagen NV (NYSE: QGEN) to $58.00 (from $55.00) while maintaining a Market Perform rating.

The analyst commented, "COVID upside drove a 3Q beat while underlying base growth was shy of our forecast and... More

Qiagen (QGEN) Tops Q3 EPS by 11c; Guides Higher

November 3, 2021 4:35 PM EDT

Qiagen (NYSE: QGEN) reported Q3 EPS of $0.58, $0.11 better than the analyst estimate of $0.47. Revenue for the quarter came in at $535 million versus the consensus estimate of $434.97 million.

GUIDANCE:

Qiagen sees FY2021 EPS of a least $2.48, versus the consensus of $2.12.

For earnings history and earnings-related data on Qiagen (QGEN) click here.

... More